Amphastar Pharmaceuticals Number of Employees 2012-2024 | AMPH
Amphastar Pharmaceuticals number of employees from 2012 to 2024. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
| Amphastar Pharmaceuticals Annual Employee Count |
| 2023 |
1,761 |
| 2022 |
1,615 |
| 2021 |
1,761 |
| 2020 |
1,980 |
| 2019 |
2,027 |
| 2018 |
2,078 |
| 2017 |
1,644 |
| 2016 |
1,541 |
| 2015 |
1,460 |
| 2014 |
1,361 |
| 2013 |
1,217 |
| 2012 |
|
| 2011 |
|
| 2009 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.186B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
